S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Day of Financial Reckoning Is Near (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
3rd Massive Dollar Upheaval Has Started (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Day of Financial Reckoning Is Near (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
3rd Massive Dollar Upheaval Has Started (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Day of Financial Reckoning Is Near (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
3rd Massive Dollar Upheaval Has Started (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Day of Financial Reckoning Is Near (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
3rd Massive Dollar Upheaval Has Started (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
NASDAQ:FWP

Forward Pharma A/S - FWP Stock Forecast, Price & News

$3.73
-0.24 (-6.05%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.65
$3.87
50-Day Range
$3.62
$5.35
52-Week Range
$3.61
$9.74
Volume
4,290 shs
Average Volume
8,040 shs
Market Capitalization
$26.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
FWP stock logo

About Forward Pharma A/S (NASDAQ:FWP) Stock

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Forward Pharma A/S Stock Down 3.0 %

Shares of Forward Pharma A/S stock traded down $0.12 on Tuesday, reaching $3.85. 200 shares of the company were exchanged, compared to its average volume of 6,789. The stock has a fifty day moving average price of $4.26 and a 200-day moving average price of $5.10. Forward Pharma A/S has a fifty-two week low of $3.61 and a fifty-two week high of $9.74.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on Forward Pharma A/S in a report on Tuesday, August 9th. They issued a "sell" rating for the company.

Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Stock News Headlines

Forward Pharma A/S News
Forward Pharma Reports FY 21 EPS of $0.02
Forward Pharma ADRs Up 26%
Forward Pharma A/S ADR
Forward Pharma A/S (FWP)
Ascendis Pharma A/S Announces Preliminary Six-...
See More Headlines
Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Company Calendar

Last Earnings
9/01/2016
Today
8/16/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FWP
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$10.09 per share

Miscellaneous

Free Float
N/A
Market Cap
$26.45 million
Optionable
Not Optionable
Beta
1.37

Key Executives

  • Mr. Florian Schonharting M.Sc. (Econ) (Age 53)
    Co-Founder & Chairman
  • Dr. Claus Bo Søndergaard Svendsen M.D. (Age 45)
    Ph.D., Chief Exec. Officer
  • Mr. Thomas Carbone (Age 65)
    VP of Fin. & Controller













FWP Stock - Frequently Asked Questions

How have FWP shares performed in 2022?

Forward Pharma A/S's stock was trading at $5.97 at the beginning of 2022. Since then, FWP shares have decreased by 37.5% and is now trading at $3.73.
View the best growth stocks for 2022 here
.

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) announced its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06.

What other stocks do shareholders of Forward Pharma A/S own?
What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

Who are Forward Pharma A/S's major shareholders?

Forward Pharma A/S's stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.20%).

How do I buy shares of Forward Pharma A/S?

Shares of FWP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $3.73.

How much money does Forward Pharma A/S make?

Forward Pharma A/S (NASDAQ:FWP) has a market capitalization of $26.45 million.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The official website for the company is www.forward-pharma.com. The biotechnology company can be reached via phone at (453) 344-4242 or via email at investors@forward-pharma.com.

This page (NASDAQ:FWP) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.